We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOM icon
2001
DMC Global
BOOM
$157M
$1.36M ﹤0.01%
61,973
+3,306
+6% +$75.7K
ECVT icon
2002
Ecovyst
ECVT
$1.14B
$1.36M ﹤0.01%
122,981
+7,247
+6% +$74.9K
PWSC
2003
DELISTED
PowerSchool Holdings, Inc.
PWSC
$1.35M ﹤0.01%
68,337
+1,691
+3% +$37K
ANIP icon
2004
ANI Pharmaceuticals
ANIP
$1.78B
$1.35M ﹤0.01%
33,985
+2,382
+8% +$100K
VRDN icon
2005
Viridian Therapeutics
VRDN
$2.67B
$1.35M ﹤0.01%
52,968
+5,715
+12% +$183K
BYND icon
2006
Beyond Meat
BYND
$277M
$1.35M ﹤0.01%
82,984
+1,744
+2% +$28.7K
MORF
2007
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.34M ﹤0.01%
35,714
+1,520
+4% +$56K
NXT icon
2008
Nextpower Inc
NXT
$15.7B
$1.33M ﹤0.01%
+36,564
New +$1.16M
KRNY icon
2009
Kearny Financial
KRNY
$599M
$1.32M ﹤0.01%
162,698
+4,117
+3% +$39.5K
JOUT icon
2010
Johnson Outdoors
JOUT
$505M
$1.32M ﹤0.01%
20,899
-354
-2% -$22.9K
CRNX icon
2011
Crinetics Pharmaceuticals
CRNX
$8.92B
$1.31M ﹤0.01%
81,904
+2,916
+4% +$54K
VNDA icon
2012
Vanda Pharmaceuticals
VNDA
$302M
$1.31M ﹤0.01%
193,608
+8,485
+5% +$59.7K
MCS icon
2013
Marcus Corp
MCS
$945M
$1.31M ﹤0.01%
82,131
+3,762
+5% +$57.7K
ANGO icon
2014
AngioDynamics
ANGO
$649M
$1.31M ﹤0.01%
126,861
+6,482
+5% +$83K
ONT
2015
Onterris Inc
ONT
$580M
$1.31M ﹤0.01%
36,712
+1,430
+4% +$64.7K
ONL
2016
Orion Office REIT
ONL
$160M
$1.31M ﹤0.01%
195,195
+7,872
+4% +$64K
REPL icon
2017
Replimune Group
REPL
$1.01B
$1.3M ﹤0.01%
73,433
+10,770
+17% +$256K
IMAX icon
2018
IMAX
IMAX
$2.66B
$1.3M ﹤0.01%
67,590
+1,204
+2% +$20.7K
RDUS
2019
DELISTED
Radius Recycling
RDUS
$1.28M ﹤0.01%
41,218
+1,907
+5% +$61.8K
THR
2020
DELISTED
Thermon Group Holdings
THR
$1.28M ﹤0.01%
51,293
+2,030
+4% +$49.5K
KURA icon
2021
Kura Oncology
KURA
$850M
$1.27M ﹤0.01%
104,003
+3,300
+3% +$41.2K
FA icon
2022
First Advantage
FA
$4.12B
$1.27M ﹤0.01%
90,825
+3,352
+4% +$45.5K
FLNA
2023
Filana Therapeutics
FLNA
$48.1M
$1.27M ﹤0.01%
52,553
+781
+2% +$21.6K
PLTK icon
2024
Playtika
PLTK
$1.12B
$1.27M ﹤0.01%
112,543
+10,287
+10% +$103K
EAF icon
2025
GrafTech
EAF
$212M
$1.26M ﹤0.01%
26,021
+959
+4% +$51.9K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.